Utility and Clinical Application of Circulating Tumor DNA (ctDNA) in Advanced Prostate Cancer by Louise Kostos, Heidi Fettke, Edmond M. Kwan, Arun A. Azad

Get full text

Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer by Louise Kostos, James P. Buteau, Michael S. Hofman, Arun A. Azad

Get full text

AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol) by Louise Kostos, Louise Kostos, James P. Buteau, James P. Buteau, James P. Buteau, Theresa Yeung, Juliana Di Iulio, Jing Xie, Anthony Cardin, Anthony Cardin, Anthony Cardin, Kwang Y. Chin, Kwang Y. Chin, Brittany Emmerson, Brittany Emmerson, Katie L. Owen, Katie L. Owen, Belinda S. Parker, Belinda S. Parker, Heidi Fettke, Heidi Fettke, Luc Furic, Luc Furic, Arun A. Azad, Arun A. Azad, Michael S. Hofman, Michael S. Hofman, Michael S. Hofman

Get full text

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotypeResearch in context by Heidi Fettke, Chao Dai, Edmond M. Kwan, Tiantian Zheng, Pan Du, Nicole Ng, Patricia Bukczynska, Maria Docanto, Louise Kostos, Siavash Foroughi, Stephen Brown, Lisa-Jane K. Graham, Kate Mahon, Lisa G. Horvath, Shidong Jia, Manish Kohli, Arun A. Azad

Get full text